(6-14-16) I was in Chicago last week to attend a housing summit hosted by the Corporation for Supportive Housing, a cutting-edge leader in developing housing for persons who are homeless, have mental illnesses and addictions, and those leaving prisons. Much of the talk was about “metrics” — being able to show results with verifiable numbers. If you can’t show that what you are doing is actually producing results, government agencies and philanthropic organizations are reluctant to support you. That being the case, I was surprised yesterday when Dr. E. Fuller Torrey sent me a copy of his latest jab at the Substance Abuse and Mental Health Services Administration (SAMHSA), which he has frequently targeted. According to the article, the federal agency that is supposed to be helping individuals with mental illnesses keeps no metrics about schizophrenia. How can that be?
Washington Funds Ignorance of Mental Illness
By E. Fuller Torrey, published June 13, 2016 in The National Review
The federal government collects accurate data on the number of pigs in Iowa, on milk cows in New York, and on turkeys in Delaware but none whatsoever on the number of people with schizophrenia. The Centers for Disease Control and Prevention keeps a long list of diseases that must be reported, including cryptosporidiosis, chlamydia, and cancer, but not schizophrenia.
This is remarkable, since schizophrenia is among our most consequential and expensive diseases. In a 2013 study, the annual economic burden of schizophrenia was estimated to be $156 billion. Three studies have reported that individuals with schizophrenia are responsible for 10 percent of all homicides in the United States; other studies suggest that people with schizophrenia — such as Jared Loughner in Tuscon, Aaron Alexis at the Washington Navy Yard, and James Holmes in Aurora, Colo. — are also responsible for up to one-third of mass killings. Even Adam Lanza in Newtown, Conn., had had a diagnosis of schizophrenia, in addition to autism spectrum disorder.
Other developed nations believe that it is important to ascertain the prevalence of schizophrenia and whether it is increasing or decreasing. For example, recent European studies have reported that schizophrenia is twice as common in England and the Netherlands as in Italy or Spain, that it has been steadily increasing in south London over three decades, and that early-onset schizophrenia is increasing in Denmark.
And what do we know about the United States? Nothing.